Edition:
United Kingdom

United Therapeutics Corp (UTHR.OQ)

UTHR.OQ on NASDAQ Stock Exchange Global Select Market

115.75USD
18 Jan 2019
Change (% chg)

$1.56 (+1.37%)
Prev Close
$114.19
Open
$115.02
Day's High
$115.82
Day's Low
$114.47
Volume
157,680
Avg. Vol
153,057
52-wk High
$143.72
52-wk Low
$100.29

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 2.67 December 19 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 3 3 3 3
(5) SELL 2 2 2 2
No Opinion 0 0 0 0
Mean Rating 3.25 3.25 3.25 3.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 4 326.87 374.00 293.67 315.10
Quarter Ending Jun-19 4 311.24 353.00 257.18 322.80
Year Ending Dec-19 12 1,239.25 1,397.72 999.77 1,173.37
Earnings (per share)
Quarter Ending Mar-19 5 2.67 3.34 1.92 2.79
Quarter Ending Jun-19 5 2.37 2.96 1.81 2.61
Year Ending Dec-19 8 9.17 10.93 7.16 9.57

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 380.42 412.70 32.27 8.48
Quarter Ending Jun-18 368.58 444.50 75.92 20.60
Quarter Ending Mar-18 395.21 389.20 6.01 1.52
Quarter Ending Dec-17 421.73 464.70 42.97 10.19
Quarter Ending Sep-17 426.43 445.50 19.07 4.47
Earnings (per share)
Quarter Ending Sep-18 3.15 2.42 0.73 23.22
Quarter Ending Jun-18 3.16 3.98 0.82 25.89
Quarter Ending Mar-18 3.57 5.57 2.00 56.08
Quarter Ending Dec-17 3.89 3.89 0.00 0.08
Quarter Ending Sep-17 3.85 6.27 2.42 62.68

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 326.87 317.37 317.37 317.37 315.10
Quarter Ending Jun-19 311.24 304.24 304.24 304.24 322.80
Year Ending Dec-19 1,239.25 1,231.72 1,231.72 1,229.38 1,173.37
Earnings (per share)
Quarter Ending Mar-19 2.67 2.67 2.67 2.67 2.79
Quarter Ending Jun-19 2.37 2.37 2.37 2.37 2.61
Year Ending Dec-19 9.17 9.37 9.37 9.34 9.57

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 1 0 1 0
Quarter Ending Jun-19 1 0 1 0
Year Ending Dec-19 1 0 1 0
Earnings
Quarter Ending Mar-19 0 0 0 0
Quarter Ending Jun-19 0 0 0 0
Year Ending Dec-19 0 1 0 1